Approach to a Whispered Child

Yıl 2017, Cilt: 9 Sayı: 2, 1 - 5, 15.03.2017

Prof. Dr. Haluk Çokuğraş

Öz

Abstract

Wheezing is a common presenting symptom of respiratory disease in infants and children. It may be eighter a benign, self limited process or  the presenting symptomof significant respiratory condition. The infant with persistent or recurrent wheezing during the first 3 years of life poses a diagnostic dilemma, which can be a source ofanxiety to both physicians and parents

Anahtar Kelimeler

Wheezing, asthma, wheezyinfant

Hışıltılı Çocuğa Yaklaşım

Öz

Hışıltı, bebeklerin ve çocukların solunum sistemi hastalıklarında sık rastlanan bir semptomdur. Bu genellikle selim gidişli, kendi kendini sınırlayan bir durumun, bazende daha ciddi bir solunum sistemi hastalığının belirtisi olabilir. Özellikle ilk üç yaştaki çocuklarda tekrarlayan ya da persiste eden hışıltı tanısal açıdan ciddi bir sorun oluşturarak anne-babalar ve hekimler açısından ciddi bir ansiyete nedeni olmaktadır.

Anahtar Kelimeler

Hışıltı, astım, hışıltılı çocuk

Kaynakça

• Kaynaklar 1.Taussig LM ,Wright AL,Holberg CJ,et al.TUCSON children’sRespratory Study:1980 to present.J Allergj Clin Immunol2003;111:661 2.Bloomberg GR.Recurrent wheezing illness in preschool-aged children:assessment and managent in primary care prac-tice.Postgard med 2009;121:48 3.Dorkin HL.Noisy breathing.In:Respiratory disease nchilden:Diagnosis and management,Loughlin GM,Eigen H(Eds),William and Wilkins,1994.p.167. 4.Garcia –Marcos L,Mallol J,Sole D ,Brand PLP and EISL gro-up .International study of wheezing in infants:risk factors inaffluent and non-affluent countries during the fırst year of lifePediatr Allergy Immunol 2010:21:878-888 5.Panitch HB.wheezing and lower airway obstruction.In:Aprac-tical guide to pediatric respiratory disease,Schidlow D, SmithD (Eds), Mosby, ST.Louis 1994.p.39. 6.Cane RS,Ranganathan SC,McKenzie SA,What do parents ofwheezy children understand by,,wheeze’’? Arch Dis Child2000;82;327. 7.Martnez FD, Wright AL, Taussig LM,et al.Asthma and whee-zing in the first six years of life.The Group Health Medical As-sociates.N Engl J Med 1995;332:133. 8.Yang KD,Ou CY, Chang JC,et al .İnfant frequent wheezing cor-related to Clara cell protein10(CC10) polymorphism and con-centration, but not allergy sensitization,in a perinatal cohortstudy.J A llergy Clin Immunol 2007;120:842-8 9.Lung N.H and Institute,B (2007).National asthma educationand prevention program.Expert panel report 3. 10.Jartti T, van den Hoogen B, Garofalo RP,et al.Metapneumo-virus and acute wheezing in children.Lancet 2002;360:1390. 11.Williams JV,Harris PA, tollefson SJ,et al.Human metapneu-movirus and lower respiratory tract disease in otherwise he-alty infants and children.N Engl J Med 2004;350:443. 12.Finder JD.Understanding airway disease in infants.Curr ProblPediatr 1999;29:65. 13.Martinati LC,Boner AL.Clinical diagnosis of wheezing in earlychildhood.Allergy 2005;50:701. 14.Pisanti A Vitiello R.Wheezing as the sole clinical manifesta-tion of cor triatrium.Pediatr Pulmonol 2000;30:346 15.Celedon JC,Litonjua AA,Ryan L,et al.Bottle feding in the bedor ctib before sleep time and wheezing in early childhood.Pe-diatrics 2002;110:e77. 16.Chpps BE.Evaluation of infants and children with refractorylower respiratory trct symptoms. Ann Allergy Asthma Immu-nol 2010;104:279. 17.Tanaç R.Hışıltılı çocuğa adım adım yaklaşım. Allerjiye adımadım yaklaşımEd.Güler N.2014 Cilt 6 Sayı:2 S:12-20.18.15.Moonnumakal SP,Fan LL.Bronchiolitis obliterans inchildren.Curr Opin Pediatr 2008 ;20:272. 19.Fischer GB,Sarria EE,Matteillo R,et al.Post infectious bronchioltis obliterans in children.Pediatr Respir Rev 2010;11:233. 20.Global iniziative for Asthma.Global strategy for asthma management and prevention.GINA-Report 2015 _Tracked.pdf 21.Brand PL,Caudri D,Eber E, et al.Classification and pharma-cologcal treatment of preschool wheezing:changes since2008.Eur Respir J 2014;431172-7 22.L. B. Bacharier, A. Boner, K.-H. Carlsen, P. A.Diagnozis andtreatment of asthma in childhood PRACTALL consensus re-port. The European Pediatric Asthma Group.Allergy2008;63:5-34. 23.Global iniziative for Asthma.Global strategy for asthma ma-nagement and prevention.GINA-Report 2016 _Tracked.pdf 24.Gastro-Rodriguez JA,Rodrigo GJ.Beta –agonists through me-tered-dose inhaler with valved holding chamber versus nebu-lizer for acute exacerbation of wheezing or asthma in child-ren under 5 years of age; a systemacreview with metaanalysis.JPediatr 2004;145:172-7 25.Deerojanawong J, Manuyakorn W, Prapphal N, Harnrutha-korn C, Sritippayawan S, Samransamruajkit R. Randomizedcontrolled trial of salbutamol aerosol therapy via metered doseinhaler-spacer vs. jet nebulizer in young children with whee-zing. Pediatr Pulmonol 2005;39:466-72. 26.Gouin S, Robidas I, Gravel J, Guimont C, Chalut D, Amre D.Prospective evaluation of two clinical scores for acute asth-ma in children 18 months to 7 years of age. Acad Emerg Med2010;17:598-603. 27.Laura Tenero, Michele Piazza, Giorgio Piacentini , Recurrentwheezing in children,Transl Pediatr 2016;5(1):31-36 28.Bisgaard H, Zielen S, Garcia- Garcia ML, Johnston SL, Gil-les L, Menten J et al. Montelukast reduces asthma exacerba-tions in 2- to 5-years –old children with intermittent asthma.AmJ Respir Crit Care Med 2005;171:315-322